UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (127) 127
life sciences & biomedicine (124) 124
humans (122) 122
middle aged (90) 90
hematology (88) 88
male (88) 88
female (87) 87
adult (72) 72
aged (62) 62
oncology (56) 56
treatment outcome (45) 45
adolescent (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
biological and medical sciences (27) 27
medical sciences (26) 26
aged, 80 and over (25) 25
transplantation (25) 25
disease-free survival (23) 23
young adult (22) 22
hematopoietic stem cell transplantation (21) 21
prognosis (18) 18
stem cells (18) 18
antineoplastic agents - therapeutic use (17) 17
follow-up studies (16) 16
retrospective studies (16) 16
combined modality therapy (15) 15
stem cell transplantation (15) 15
transplantation, homologous (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
care and treatment (14) 14
chemotherapy (14) 14
remission induction (14) 14
transplantation, autologous (14) 14
hematologic and hematopoietic diseases (13) 13
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (13) 13
multiple myeloma - drug therapy (13) 13
neoplasm staging (13) 13
recurrence (13) 13
survival analysis (13) 13
abridged index medicus (12) 12
antineoplastic agents - administration & dosage (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
rituximab (12) 12
survival rate (12) 12
analysis (10) 10
hematology, oncology and palliative medicine (10) 10
hematopoietic stem cell transplantation - methods (10) 10
immunophenotyping (10) 10
acute myeloid leukemia (9) 9
bone marrow (9) 9
cyclophosphamide - administration & dosage (9) 9
gene expression (9) 9
hematopoietic stem cells (9) 9
leukemia (9) 9
multiple myeloma - mortality (9) 9
prednisone - administration & dosage (9) 9
risk factors (9) 9
thalidomide - administration & dosage (9) 9
tumors (9) 9
vincristine - administration & dosage (9) 9
cancer (8) 8
doxorubicin - administration & dosage (8) 8
flow cytometry (8) 8
health aspects (8) 8
research (8) 8
rituximab - administration & dosage (8) 8
transplantation conditioning - methods (8) 8
child (7) 7
child, preschool (7) 7
chronic myeloid leukemia (7) 7
development and progression (7) 7
disease progression (7) 7
drug administration schedule (7) 7
drug therapy (7) 7
hematopoietic stem cell transplantation - adverse effects (7) 7
italy - epidemiology (7) 7
kaplan-meier estimate (7) 7
minimal residual disease (7) 7
multiple myeloma (7) 7
salvage therapy (7) 7
transplants & implants (7) 7
acute disease (6) 6
antineoplastic agents - adverse effects (6) 6
benzamides (6) 6
further section (6) 6
fusion proteins, bcr-abl - genetics (6) 6
genetic aspects (6) 6
hodgkin disease - pathology (6) 6
hodgkin disease - therapy (6) 6
imatinib mesylate (6) 6
italy (6) 6
leukemia, myelogenous, chronic, bcr-abl positive - genetics (6) 6
lymphoma (6) 6
medicine (6) 6
prospective studies (6) 6
pyrimidines - administration & dosage (6) 6
settore med/15 - malattie del sangue (6) 6
thalidomide - analogs & derivatives (6) 6
time factors (6) 6
vidarabine - analogs & derivatives (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 01/2012, Volume 119, Issue 4, pp. 933 - 939
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Immunopathology | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Pulmonary Embolism - prevention & control | Venous Thrombosis - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Incidence | Thalidomide - analogs & derivatives | Venous Thromboembolism - prevention & control | Multiple Myeloma - drug therapy | Antineoplastic Agents - adverse effects | Aspirin - adverse effects | Adult | Female | Venous Thrombosis - prevention & control | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Venous Thromboembolism - epidemiology | Platelet Aggregation Inhibitors - adverse effects | Thalidomide - adverse effects | Lenalidomide | Risk Factors | Anticoagulants - therapeutic use | Thalidomide - administration & dosage | Anticoagulants - adverse effects | Israel - epidemiology | Venous Thrombosis - epidemiology | Venous Thromboembolism - chemically induced | Italy - epidemiology | Pulmonary Embolism - chemically induced | Thalidomide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 10, pp. 895 - 905
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Immunopathology | General aspects | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Immunoglobulinopathies | Medical sciences | Immunodeficiencies. Immunoglobulinopathies | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Transplantation, Autologous | Consolidation Chemotherapy | Antineoplastic Agents, Alkylating - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Melphalan - adverse effects | Adult | Maintenance Chemotherapy | Neutropenia - chemically induced | Thalidomide - adverse effects | Prednisone - administration & dosage | Prednisone - adverse effects | Kaplan-Meier Estimate | Combined Modality Therapy | Thalidomide - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Aged | Antineoplastic Agents, Alkylating - adverse effects | Stem Cell Transplantation - adverse effects | Complications and side effects | Care and treatment | Patient outcomes | Multiple myeloma | Stem cells | Transplantation | Research | Health aspects | Autografts | Chemotherapy | Cell survival | Transplants & implants | Melphalan | Stem cell transplantation | Death | Prednisone | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 1, pp. 43 - 53
Journal Article
Blood, ISSN 0006-4971, 07/2012, Volume 120, Issue 1, pp. 9 - 19
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 730 - 737
Journal Article
Journal Article